This Plain Language Summary of publication article (PLSP) from Pain Management investigated the effectiveness of relugolix combination therapy compared to a placebo in women with uterine fibroids experiencing moderate to severe pain (menstrual or non-menstrual). Over 24 weeks of daily oral treatment, many women taking relugolix combination therapy reported minimal or no pain during the last 5 weeks of treatment.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Relugolix Combination Therapy for Uterine Leiomyoma–Associated Pain in the LIBERTY Randomized Trials’ and was published in Obstetrics and Gynecology

Visit ACOG using the link to read the original article.